# Human Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/human-health

- Industry: Healthcare IT
- Headquarters: Australia
- Website: www.human.health/
- Total disclosed funding: $16M
- Latest round: Seed (Oct 7, 2025)
- Investors on record: 6

## About

Based in Australia, Human Health operates as a digital health platform dedicated to managing chronic conditions via a mobile application, enhancing patient engagement and healthcare outcomes for users. Founded in 2021 by former Canva product leaders Georgia V. and Kate Lambridis and headquartered in Australia, specializes in a digital health platform aimed at managing chronic conditions. In October 2025, Human Health raised GBP 4.1 million in seed funding led by new investor LocalGlobe, with participation from returning investors Skip Capital and AirTree Ventures. Individual investors also participated in the round. The founder's background is not extensively detailed, but the company has shown continuous growth since its inception.

Human Health offers a digital health platform that focuses on managing chronic conditions through an innovative mobile application. The core offering includes a user-friendly app that allows individuals to create personalized health profiles, track a wide array of symptoms, and monitor treatment plans that encompass medications, therapies, and supplements. This application assists users in managing conditions such as anxiety, depression, PTSD, ADHD, autism, and various chronic illnesses. By providing tailored symptom tracking and insights, the app aims to enhance patient engagement and improve healthcare outcomes. Human Health serves a diverse clientele, including patients, caregivers, and healthcare practitioners, primarily in North America and Europe, where there is a growing demand for personalized health management solutions.

Human Health generates revenue through a subscription-based model that provides users with access to advanced features within its app. The firm structures its transactions to facilitate direct-to-consumer sales, allowing individual users to subscribe to various service tiers that offer different levels of functionality and support. The app's offerings include premium features that enhance symptom tracking capabilities and insights, aimed at improving user experiences and health management. Additionally, the company engages in partnerships with healthcare providers and institutions, creating a B2B revenue stream where practitioners can utilize the platform to manage their patients' treatment plans effectively.

In October 2025, Human Health raised GBP 4.1 million in Seed funding to accelerate smarter features, expand patient use cases, and scale its precision health platform. The company plans to introduce upcoming new products that enhance the user experience and broaden its market reach. Specifically, Human Health aims to expand into new markets, focusing on increasing its presence in Europe and targeting additional regions by late 2026. This approach, supported by the recent funding, will help facilitate the development of innovative solutions and strengthen the company's competitive position in digital health.

## Funding rounds

- Seed, Oct 7, 2025, $5.5M — AirTree Ventures, Scale Investors, LocalGlobe, Skip Capital, Everywhere Ventures, Aliavia Ventures
- Seed, Jan 1, 2022, $10M — AirTree Ventures, Skip Capital

## Investors

- AirTree Ventures (https://capitalatlas.ai/funds/airtree-ventures) — Seed
- Skip Capital (https://capitalatlas.ai/funds/skip-capital) — Seed
- Scale Investors (https://capitalatlas.ai/funds/scale-investors) — Seed
- LocalGlobe (https://capitalatlas.ai/funds/localglobe) — Seed
- Everywhere Ventures (https://capitalatlas.ai/funds/everywhere-ventures) — Seed
- Aliavia Ventures (https://capitalatlas.ai/funds/aliavia-ventures) — Seed